¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"T4"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
3
ÄÚµå
¿µ¹®
ÇѱÛ
T42.7
Antiepileptic and sedative-hypnotis drugs, unspecified
»ó¼¼ºÒ¸íÀÇ Ç×°£ÁúÁ¦ ¹× ÁøÁ¤-¼ö¸é¼º ¾à¹°
T46.6
Antihyperlipidaemic and antiarteriosclerotic drugs
Ç×°íÁöÁúÇ÷Áõ ¹× Ç×µ¿¸Æ°æÈÁõ ¾à¹°
T45.1
Antineoplastic and immunosuppressive drugs
Ç׽Żý¹°¼º ¾à¹° ¹× ¸é¿ª ¾ïÁ¦¼º ¾à¹°
T42.8
Antiparkinsonism drugs and other central muscle-tone depressants
ÇׯÄŲ½¼Á¦ ¾à¹° ¹× ±âŸ ÁßÃß¼º ±ÙÀ°±äÀåµµ ¾ïÁ¦Á¦
T49.1
Antipruritics
°¡·Á¿ò¾à(Ç×°¡·Á¿òÁ¦)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½